Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Shares Issued (2019 - 2025)

Biodesix (BDSX) has disclosed Shares Issued for 7 consecutive years, with $2.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Issued rose 104.17% year-over-year to $2.3 million, compared with a TTM value of $2.3 million through Dec 2025, up 9268.0%, and an annual FY2025 reading of $7.3 million, up 29180.0% over the prior year.
  • Shares Issued was $2.3 million for Q4 2025 at Biodesix, up from -$55.6 million in the prior quarter.
  • Across five years, Shares Issued topped out at $55.6 million in Q3 2024 and bottomed at -$55.6 million in Q4 2024.
  • Average Shares Issued over 5 years is $2.7 million, with a median of $204000.0 recorded in 2021.
  • The sharpest move saw Shares Issued skyrocketed 7772.55% in 2022, then crashed 555.74% in 2024.
  • Year by year, Shares Issued stood at $15.6 million in 2021, then plummeted by 213.41% to -$17.7 million in 2022, then soared by 168.94% to $12.2 million in 2023, then plummeted by 555.74% to -$55.6 million in 2024, then soared by 104.17% to $2.3 million in 2025.
  • Business Quant data shows Shares Issued for BDSX at $2.3 million in Q4 2025, -$55.6 million in Q4 2024, and $55.6 million in Q3 2024.